CSPHF
Price
$0.89
Change
-$0.11 (-11.00%)
Updated
Oct 21 closing price
Capitalization
1.06B
Intraday BUY SELL Signals
HYFT
Price
$1.80
Change
+$0.04 (+2.27%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
81.23M
Intraday BUY SELL Signals
Interact to see
Advertisement

CSPHF vs HYFT

Header iconCSPHF vs HYFT Comparison
Open Charts CSPHF vs HYFTBanner chart's image
CSTONE PHARMACEUTICALS
Price$0.89
Change-$0.11 (-11.00%)
Volume$500
Capitalization1.06B
MindWalk Holdings
Price$1.80
Change+$0.04 (+2.27%)
Volume$2.11K
Capitalization81.23M
CSPHF vs HYFT Comparison Chart in %
CSPHF
Daily Signal:
Gain/Loss:
HYFT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CSPHF vs. HYFT commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Hold and HYFT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (CSPHF: $0.89 vs. HYFT: $1.76)
Brand notoriety: CSPHF and HYFT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 62% vs. HYFT: 26%
Market capitalization -- CSPHF: $1.05B vs. HYFT: $83.54M
CSPHF [@Biotechnology] is valued at $1.05B. HYFT’s [@Biotechnology] market capitalization is $83.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileHYFT’s FA Score has 0 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • HYFT’s FA Score: 0 green, 5 red.
According to our system of comparison, HYFT is a better buy in the long-term than CSPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSPHF’s TA Score shows that 3 TA indicator(s) are bullish while HYFT’s TA Score has 3 bullish TA indicator(s).

  • CSPHF’s TA Score: 3 bullish, 3 bearish.
  • HYFT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CSPHF is a better buy in the short-term than HYFT.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while HYFT (@Biotechnology) price change was -1.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPHF($1.06B) has a higher market cap than HYFT($81.2M). HYFT YTD gains are higher at: 327.496 vs. CSPHF (296.009).
CSPHFHYFTCSPHF / HYFT
Capitalization1.06B81.2M1,303%
EBITDAN/A-28.59M-
Gain YTD296.009327.49690%
P/E RatioN/AN/A-
RevenueN/A25.2M-
Total CashN/A32.4M-
Total DebtN/A3.72M-
FUNDAMENTALS RATINGS
HYFT: Fundamental Ratings
HYFT
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSPHFHYFT
RSI
ODDS (%)
Bullish Trend 2 days ago
33%
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
41%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
41%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
34%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
30%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
46%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CSPHF
Daily Signal:
Gain/Loss:
HYFT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHASX10.77N/A
N/A
JHancock Multi-Asset Absolute Return R6
HWGIX16.13N/A
N/A
Hotchkis & Wiley Global Value I
FADTX133.88N/A
N/A
Fidelity Advisor Technology A
BGIVX15.46-0.11
-0.69%
Baillie Gifford International Alpha 5
PGIEX34.16-0.36
-1.04%
Putnam Focused Equity C

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
BCAB - CSPHF
9%
Poorly correlated
+20.59%
SIGY - CSPHF
8%
Poorly correlated
N/A
NBTX - CSPHF
7%
Poorly correlated
-0.41%
HYFT - CSPHF
5%
Poorly correlated
+2.33%
More

HYFT and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYFT has been loosely correlated with LPCN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HYFT jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYFT
1D Price
Change %
HYFT100%
+2.33%
LPCN - HYFT
43%
Loosely correlated
+7.67%
CGTX - HYFT
28%
Poorly correlated
N/A
PRME - HYFT
27%
Poorly correlated
-7.59%
TAOX - HYFT
27%
Poorly correlated
+10.49%
TNGX - HYFT
27%
Poorly correlated
+0.25%
More